PMSF, a nerve agent, is used to manufacture HPV vaccines, but it is not supposed to be in the final product. However, new research documents its presence in Merck’s Gardasil and Gardasil 9 HPV vaccines.
In “From Pap Smear to the HPV Vaccine: The Cervical Cancer Prevention Industry,” Dr. Sing Hang Lee details how government and industry collaborated to sideline the Pap test, an effective diagnostic tool for cervical cancer, in order to push HPV vaccines.
“One of the hardest things for a mother to hear is your daughter will not be able to have children … People need to know these risks are very real.”
This is the sixth Gardasil lawsuit Baum Hedlund and CHD Chairman Robert F. Kennedy, Jr. filed against Merck, challenging the company’s dangerous and defective HPV vaccine for causing severe and life-changing injuries.
“I want to warn kids of the terrible risks for this vaccine and let other injured girls know that they are not alone. The Gardasil vaccine stole my life. Before Gardasil, my future was filled with endless possibilities.”
The national law firm of Baum Hedlund Aristei & Goldman filed a Gardasil lawsuit against Merck. The lawsuit asserts Merck purposely downplayed the risk of Gardasil’s ingredients, and secret and potentially hazardous DNA particles.
Don’t miss this webinar featuring leading experts on the human papilloma virus and the HPV vaccine. Attorneys Mary Holland and Kim Mack Rosenberg, co-authors of The HPV Vaccine on Trial, join internationally recognized OB/GYN and author Christiane Northrup, MD to share what they’ve learned about both the virus and the vaccine after years of investigation. They’ll be covering risks and benefits of the vaccine, natural HPV treatments, parental rights, the connection between HPV and cancer, the biggest misconceptions of this highly controversial vaccine and much more.
Gulf war illness, post-HPV vaccination syndrome, and Macrophagic Myofasciitis. Similar disabling conditions possibly linked to vaccine-induced autoimmune dysautonomia.
Several epidemiological studies suggest a link between multiple vaccinations at the time of the military operation and the development of Gulf War iIlness, Macrophagic Myofasciitis and Post-HPV Vaccination Syndrome.
Download 1. No HPV vaccine has been proven to prevent any cancer of any kind ever. The Merck Gardasil and Gardasil 9 clinical trials showed that the vaccines reduce abnormal cervical growth, not cervical or any other cancer. Merck’s cancer prevention promise will take decades to verify. The median age of diagnosis for cervical cancer […]
Bombshell Study Questioning HPV Vaccine Efficacy Appears as the UK’s Cervical Cancer Rates Rise in Young
A blistering new study by British researchers, new data showing that cervical cancer rates are surging in British 25- to 29-year-olds (one of the very age groups that first received the HPV vaccine), raises numerous questions about the HPV vaccination’s effectiveness.
HPV Article Withdrawn Without Detailed Explanation by Journal of Toxicology and Environmental Health
In June 2018, the Journal of Toxicology and Environmental Health, Part A published my article “A lowered probability of pregnancy in females in the USA aged 25-29 who received a human papillomavirus vaccine injection”. Data revealed that 60% of women who had not received the HPV vaccine had been pregnant at least once, while only 35% of HPV vaccine recipients had ever conceived.
Molecular mimicry: Body Confusion of “Self” and “Non-Self” (More Evidence on HPV Vaccines and Autoimmunity)
The powerful government-pharmaceutical industry partnership that has been foisting human papillomavirus (HPV) vaccination on girls and boys around the world since 2006 now has working-age adults within its sights. Merck’s Gardasil 9 received U.S. Food and Drug Administration (FDA) approval for expanded use in the 27-45 age group in late 2018, and there are signs that a campaign is afoot to achieve the same end result in other countries.
Translation (editor’s notes in parentheses) – Moderator: Good evening. Welcome to Westpol. Ten years ago, it was a world sensation. The cervical cancer vaccine was the first cancer vaccine. A breakthrough in cancer prevention. It certainly protected many girls and women from the disease. But even this vaccine can have side effects. And this even […]
Washington, DC – The CDC Advisory Committee for Immunization Practices (ACIP) will consider recommending the Human Papilloma Virus (HPV) vaccine to both women and men ages 27 to 45 in a meeting Feb. 27-28, 2019. This recommendation would possibly expose over 80 million adults to the Gardasil 9 vaccine.
This spring, the United States reported its lowest birth rate in 30 years, despite an economic boom. Finland’s birth rate plummeted to a low not seen in 150 years.
One of the most difficult questions parents can face is: do we vaccinate our children?
For some, the answer is immediate; for others, not so. Some parents are confused or mistrusting of the vaccine industry and, in turn, anyone administering their products; while others are first in the queue to ensure that their children get all the recommended shots. Recent events, unfolding globally and reported in the leading medical journals, will not make that decision any easier.
Cancer strikes fear in people’s hearts around globe. So the appearance of a vaccine to prevent cancer–as we are assured the human papillomavirus (HPV) vaccine will–seemed like a game-changer. Since 2006, over eighty countries have approved the vaccine, with glowing endorsements from the world’s foremost medical authorities. Bringing in over $2.5 billion in annual sales, the HPV vaccine is a pharmaceutical juggernaut. Yet scandal now engulfs it worldwide.
A Cochrane review that gave the all-clear to vaccines designed to prevent cervical cancer did not include all the relevant trials and ignored possible sources of bias, a new analysis has found.
Garbage In, Garbage Out: Researchers Dress Down Cochrane for Its Flawed and Biased Review of HPV Vaccines
In May 2018, Cochrane, the research organization that bills itself as the “international gold standard for high quality, trusted information,” released a flattering review of human papillomavirus (HPV) vaccines. The Cochrane review methodology involves pulling together data from clinical trials and reviewing the assembled evidence in what is supposed to be a standardized, systematic and neutral manner.
New study: Vaccine Manufacturers and FDA Regulators Used Statistical Gimmicks to Hide Risks of HPV Vaccines
A new study published in Clinical Rheumatology exposes how vaccine manufacturers used phony placebos in clinical trials to conceal a wide range of devastating risks associated with HPV vaccines. Instead of using genuine inert placebos and comparing health impacts over a number of years, as is required for most new drug approvals, Merck and GlaxoSmithKline spiked their placebos with a neurotoxic aluminum adjuvant and cut observation periods to a matter of months.
The number of studies that show that partial immunization via available HPV (human papillomavirus) vaccines is not only insufficient at reducing overall HPV infection rates; the vaccines actually cause rarer, more lethal types of HPV to sweep in and the net effect could be devastating increases in HPV-related cancers.